American Family Pharmacy

What American Family Pharmacy does

American Family Pharmacy (AFP) is described in its firmographic profile as a private, Indianapolis-based company that develops, manufactures, and distributes FDA-approved over-the-counter medications to small and large scale retailers. The firm was founded in 2011 and reports a headcount of 1–10 employees, consistent with a micro-cap manufacturer or contract distributor. The company is privately held with no public ticker, no disclosed parent organization, and no subsidiaries on record. One executive is identified — Saumin Calcuttawala, listed as Vice President.

The business model is described as a manufacturer-distributor relationship with retail channels, but no specific SKUs, product categories, pricing terms, customer logos, or channel-partner relationships are disclosed. No certifications, FDA registrations, manufacturing facilities, or product-launch history appear in the available source material. A 2013 funding round is recorded with $0 raised and undisclosed investors, indicating that no material external capital has been formally secured. No acquisitions, mergers, partnerships, or geographic expansions are on record.

The most material operational signal in the source material is that the company's primary web domain, AfPharmacy.com, is currently listed for resale on HugeDomains.com at $1,595 (or via a 24-month payment plan). This indicates the digital storefront is no longer being used to support active operations, and raises a substantive question about whether the entity is currently operating at commercial scale. No customer-facing digital presence, app, social media accounts, or press activity is disclosed. The overall evidence base is thin, and any diligence conclusion must account for the gap between the firm's stated business description and the absence of corroborating operational signals.

Name

American Family Pharmacy

Legal name

American Family Pharmacy

Website

https://afpharmacy.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales

Pricing tiers

Distribution channels1 record

Marketing channels1 record

Core offering

American Family Pharmacy (AFP) develops, manufactures, and distributes FDA-approved over-the-counter medications. The company's products are sold to small and large scale retailers in the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• FDA-approved over-the-counter medications Over-the-counter (OTC) medications developed, manufactured, and distributed by American Family Pharmacy under FDA approval, sold to small and large scale retailers for resale to end consumers.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights1 record

Direct peers

• Perrigo Company: Perrigo is the largest U.S. private-label OTC pharmaceutical manufacturer and distributor, selling store-brand equivalents of branded drugs to major retail chains. American Family Pharmacy's stated business model — developing, manufacturing, and distributing FDA-approved OTC medications to retailers — is a smaller-scale version of Perrigo's core franchise.
• Prestige Consumer Healthcare: Prestige develops, manufactures, and distributes OTC healthcare products (Monistat, BC Powder, Chloraseptic, etc.) to mass-market and drug retailers. Its hybrid branded-OTC model and emphasis on retail distribution make it directly comparable to AFP's described activities.

Broad incumbents

• Apotex Inc. Apotex is one of the largest Canadian-headquartered generic pharmaceutical manufacturers with U.S. distribution. It develops and manufactures FDA-approved generic and OTC medications across therapeutic categories and supplies them to retailers and wholesalers, comparable in activity scope to AFP though at far greater scale.
• Amneal Pharmaceuticals: Amneal develops, manufactures, and distributes generic and specialty pharmaceuticals including OTC products across the U.S. Its integrated manufacturing-to-retailer model mirrors AFP's described business, and its Indianapolis-area presence (in the same pharma corridor) makes it geographically comparable.
• Teva Pharmaceutical Industries: Teva is one of the world's largest generic and OTC pharmaceutical manufacturers, distributing a broad portfolio of FDA-approved products through U.S. retail channels. Comparable in regulatory profile and product category to AFP's stated offering.
• Viatris: Viatris (formed from Mylan and Upjohn) is a global pharmaceutical manufacturer with a significant OTC and generics portfolio distributed through U.S. retailers. Its branded-generic hybrid model and broad retailer relationships make it a relevant scaled comparable.
• Sandoz (Novartis division): Sandoz is the global generics and biosimilars arm of Novartis, producing FDA-approved generic and OTC pharmaceuticals for retail distribution worldwide. Comparable in regulatory and product category terms to AFP, though operating at vastly greater scale.
• Aurobindo Pharma: Aurobindo is a major Indian-headquartered generic pharmaceutical manufacturer with FDA-approved manufacturing and significant U.S. distribution through retailers and wholesalers. Its vertically integrated OTC/generic model parallels AFP's described activities.
• Sun Pharmaceutical Industries: Sun Pharma is a global specialty and generic pharmaceutical manufacturer with FDA-approved facilities and U.S. retail/wholesale distribution. Its product breadth and regulatory footprint are comparable in category, though orders of magnitude larger than AFP.
• Glenmark Pharmaceuticals: Glenmark develops, manufactures, and markets generic and OTC pharmaceutical products with U.S. distribution to retailers. Comparable business model with a focus on FDA-approved off-patent medications distributed through retail channels.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Family Pharmacy